Inventor
KIRSCHBERG THORSTEN A
US41 patents
⚠️ This page may combine multiple inventors who share the name “KIRSCHBERG THORSTEN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
15 patentsUS9139604B2Sep 22, 2015
Antiviral phosphonate analogs
GILEAD SCIENCES INC42 citations97
US8871785B2Oct 28, 2014
Antiviral phosphonate analogs
GILEAD SCIENCES INC49 citations97
US7645747B2Jan 12, 2010
Therapeutic phosphonate compounds
GILEAD SCIENCES INC60 citations97
US9878995B2Jan 30, 2018
Cot modulators and methods of use thereof
GILEAD SCIENCES INC14 citations92
US8841278B2Sep 23, 2014
Antiviral compounds
GILEAD SCIENCES INC20 citations92
US8822430B2Sep 2, 2014
Antiviral compounds
GILEAD SCIENCES INC17 citations92
US11066414B2Jul 20, 2021
Cot modulators and methods of use thereof
GILEAD SCIENCES INC10 citations85
US10577352B2Mar 3, 2020
Cot modulators and methods of use thereof
GILEAD SCIENCES INC10 citations84
US10316017B2Jun 11, 2019
COT modulators and methods of use thereof
GILEAD SCIENCES INC12 citations84
US10059695B2Aug 28, 2018
Cot modulators and methods of use thereof
GILEAD SCIENCES INC12 citations84
US9815818B2Nov 14, 2017
Cot modulators and methods of use thereof
GILEAD SCIENCES INC13 citations84
US10328053B2Jun 25, 2019
Substituted pyrrolizine compounds and uses thereof
GILEAD SCIENCES INC4 citations83
US11905299B2Feb 20, 2024
Cot modulators and methods of use thereof
GILEAD SCIENCES INC3 citations74
US10874640B2Dec 29, 2020
Substituted pyrrolizine compounds and uses thereof
GILEAD SCIENCES INC2 citations72
US12161625B2Dec 10, 2024
Substituted pyrrolizine compounds and uses thereof
GILEAD SCIENCES INC0 citations61
GUO HONGYAN
5 patentsUS8088368B2Jan 3, 2012
Antiviral compounds
GUO HONGYAN86 citations98
US8273341B2Sep 25, 2012
Antiviral compounds
GUO HONGYAN47 citations97
US8669234B2Mar 11, 2014
Antiviral compounds
GUO HONGYAN25 citations96
US8575118B2Nov 5, 2013
Antiviral compounds
GUO HONGYAN25 citations95
US8106064B2Jan 31, 2012
Pyrimidine-2,4-dione HIV reverse transcriptase inhibitors
GUO HONGYAN6 citations72
CELLGATE INC
5 patentsUS6669951B2Dec 30, 2003
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC148 citations98
US6593292B1Jul 15, 2003
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC163 citations98
US6730293B1May 4, 2004
Compositions and methods for treating inflammatory diseases of the skin
CELLGATE INC83 citations97
US7229961B2Jun 12, 2007
Compositions and methods for enhancing drug delivery across and into ocular tissues
CELLGATE INC55 citations95
US6759387B2Jul 6, 2004
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC67 citations95
TERNS INC
4 patentsUS10800767B2Oct 13, 2020
Thyroid hormone receptor beta agonist compounds
TERNS INC11 citations83
US11203587B2Dec 21, 2021
Thyroid hormone receptor beta agonist compounds
TERNS INC6 citations71
US10889571B2Jan 12, 2021
Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias
TERNS INC4 citations71
US10919911B2Feb 16, 2021
Tricyclic ASK1 inhibitors
TERNS INC0 citations50
TERNS PHARMACEUTICALS INC
4 patentsUS12240835B2Mar 4, 2025
Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity
TERNS PHARMACEUTICALS INC1 citations62
US12454524B2Oct 28, 2025
(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias
TERNS PHARMACEUTICALS INC0 citations60
US12528791B2Jan 20, 2026
Thyroid hormone receptor beta agonist compounds
TERNS PHARMACEUTICALS INC0 citations50
US12398127B2Aug 26, 2025
Thyroid hormone receptor beta agonist compounds
TERNS PHARMACEUTICALS INC0 citations50
ROTHBARD JONATHAN B
3 patentsUS8623833B2Jan 7, 2014
Compositions and methods for enhancing drug delivery across and into epithelial tissues
ROTHBARD JONATHAN B18 citations91
US8729010B2May 20, 2014
Compositions and methods for enhancing drug delivery across and into ocular tissues
ROTHBARD JONATHAN B5 citations83
US8278264B2Oct 2, 2012
Compositions and methods for enhancing drug delivery across and into ocular tissues
ROTHBARD JONATHAN B7 citations83
GILEAD PHARMASSET LLC
2 patentsBIOMEA FUSION INC
2 patentsUS12215113B2Feb 4, 2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide]
BIOMEA FUSION INC0 citations52
US11945785B2Apr 2, 2024
Pyrazine compounds as inhibitors of FLT3
BIOMEA FUSION INC0 citations46